Paysign (NASDAQ:PAYS – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.05, FiscalAI reports. The company had revenue of $28.25 million during the quarter, compared to analyst estimates of $26.36 million. Paysign had a return on equity of 21.74% and a net margin of 11.38%. Paysign updated its FY 2026 guidance to 0.350-0.370 EPS and its Q3 2026 guidance to 0.090-0.100 EPS.
Here are the key takeaways from Paysign’s conference call:
- Record second-quarter results included revenue of $28.3 million, up 48% year over year, net income of $6.8 million, and adjusted EBITDA of $9.6 million, up 113%; gross margin expanded to 63.3%.
- Patient Affordability remained the primary growth engine, with revenue rising 89% to $14.6 million, claims increasing approximately 54%, and active programs reaching 148, up from 97 a year ago. Management expects to match or exceed 55 net program additions in 2026 and sees a substantial addressable market.
- The plasma business showed recovery, with revenue up 21.4% to $13 million and monthly revenue per center reaching $7,699, its highest level since the third quarter of 2024. Management said the prior inventory overhang has largely normalized, although the center count declined to 561 after closures.
- Paysign raised its full-year 2026 outlook to revenue of $114 million-$117 million, gross margin of 62%-63%, GAAP net income of $21.5 million-$23 million, and adjusted EBITDA of $35 million-$38 million. The company ended the quarter with $27.4 million in unrestricted cash and no bank debt.
- Management expects fourth-quarter profitability to be weaker than the third quarter because of seasonal mix, holiday-related software capitalization effects, higher expected taxes, and planned hiring to support continued Patient Affordability growth. Full-year GAAP earnings also include a one-time, non-cash $990,000 benefit tied to the Gamma acquisition earn-out liability.
Paysign Stock Up 3.3%
PAYS stock opened at $9.59 on Thursday. The firm has a market capitalization of $536.14 million, a PE ratio of 56.41 and a beta of 0.74. Paysign has a twelve month low of $3.08 and a twelve month high of $9.60. The stock has a 50-day simple moving average of $8.09 and a two-hundred day simple moving average of $6.00.
Key Stories Impacting Paysign
- Positive Sentiment: Q2 results significantly exceeded expectations: Paysign reported record revenue of approximately $28.3 million, up 48% year over year, versus the $26.36 million consensus estimate. Adjusted earnings were $0.11 per share, beating expectations of $0.06, while net margin reached 11.38% and return on equity was 21.74%. Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook
- Positive Sentiment: Third-quarter guidance was well above consensus: Paysign forecast EPS of $0.09–$0.10, compared with the $0.07 analyst estimate, and revenue of $28.5 million–$30.0 million versus the $27.0 million consensus. This signals continued momentum into the next quarter.
- Positive Sentiment: Full-year revenue outlook was raised: Fiscal 2026 revenue guidance of $114 million–$117 million is substantially above the $108.6 million consensus estimate, suggesting management expects growth in prepaid card, pharmaceutical patient-affordability and payment-processing businesses. Management also highlighted record net income, adjusted EBITDA and expanding margins on the earnings call. Paysign Q2 2026 Earnings Call Transcript
- Neutral Sentiment: Full-year EPS guidance of $0.35–$0.37 brackets the $0.36 consensus estimate, so the outlook is broadly in line on earnings even though the revenue forecast is ahead of expectations.
- Neutral Sentiment: The shares’ strong recent performance and elevated valuation, including a reported price-to-earnings ratio above 56, may leave less room for disappointment despite the favorable operating trends.
Insider Activity
In other news, Director Bruce A. Mina sold 10,000 shares of the stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $7.09, for a total value of $70,900.00. Following the sale, the director directly owned 258,500 shares of the company’s stock, valued at approximately $1,832,765. This represents a 3.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Mark Newcomer sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $9.38, for a total transaction of $469,000.00. Following the completion of the transaction, the chief executive officer owned 9,222,027 shares of the company’s stock, valued at $86,502,613.26. This trade represents a 0.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 221,736 shares of company stock worth $1,803,479 over the last ninety days. Company insiders own 24.50% of the company’s stock.
Institutional Investors Weigh In On Paysign
Large investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new position in Paysign in the 2nd quarter worth about $30,000. BNP Paribas Financial Markets increased its position in shares of Paysign by 99.8% in the third quarter. BNP Paribas Financial Markets now owns 6,912 shares of the company’s stock worth $43,000 after purchasing an additional 3,453 shares during the last quarter. Jane Street Group LLC purchased a new stake in Paysign in the first quarter valued at approximately $51,000. Quarry LP bought a new stake in Paysign during the third quarter valued at approximately $54,000. Finally, Qube Research & Technologies Ltd purchased a new position in Paysign in the 3rd quarter worth approximately $67,000. Institutional investors own 25.89% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently weighed in on PAYS. Weiss Ratings upgraded shares of Paysign from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, July 29th. DA Davidson reaffirmed a “buy” rating and issued a $9.00 price objective on shares of Paysign in a report on Wednesday, May 13th. Barrington Research set a $11.00 price objective on shares of Paysign in a research note on Monday. Finally, Wall Street Zen cut shares of Paysign from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 13th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $10.33.
Get Our Latest Analysis on Paysign
About Paysign
Paysign, Inc (NASDAQ:PAYS) is a U.S.-based financial technology company specializing in prepaid payment solutions. Through its cloud-based platform, the company enables corporations, government agencies and payroll providers to issue and manage stored-value cards, digital wallets and disbursement programs. Paysign’s offerings span gift and incentive cards, payroll and earned-wage access cards, government benefit distribution, tax refund solutions and health savings account disbursements.
The company’s flagship Paysign Experience Platform provides configurable card programs with real-time transaction reporting, fraud monitoring and regulatory compliance tools.
Further Reading
- Five stocks we like better than Paysign
- Why Analysts Are Bullish on a Stock That’s Down 20%
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.
